Edges in Network
| Network | GSE25065_top8000 - GSE25065 - SiGN-BN NNSR |
| Network Description | Validation cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
| Node | LAPTM5 |
| Upstream (Parents) |
|---|
| (<<) SRGN → LAPTM5 |
| (<<) ITGB2 → LAPTM5 |
| Downstream (Children) |
|---|
| LAPTM5 → NPL (>>) |
| LAPTM5 → PTPN22 (>>) |
| LAPTM5 → CASC1 (>>) |
| LAPTM5 → LCP2 (>>) |
| LAPTM5 → SRGN (>>) |
| LAPTM5 → HLA-DRA (>>) |
| LAPTM5 → LILRA2 (>>) |
| LAPTM5 → CHST11 (>>) |
| LAPTM5 → ALOX5 (>>) |
| LAPTM5 → MMP9 (>>) |
| LAPTM5 → TBXAS1 (>>) |
| LAPTM5 → TAF1B (>>) |
| LAPTM5 → TLE2 (>>) |
| LAPTM5 → CD14 (>>) |
| LAPTM5 → CTSS (>>) |
| LAPTM5 → SAT1 (>>) |
| LAPTM5 → TFEC (>>) |
| LAPTM5 → S100A4 (>>) |
| LAPTM5 → TYROBP (>>) |
| LAPTM5 → SAMSN1 (>>) |
| LAPTM5 → SIGLEC7 (>>) |
| LAPTM5 → ITGB2 (>>) |
| LAPTM5 → CD53 (>>) |
| LAPTM5 → PLEKHO2 (>>) |
| LAPTM5 → HCLS1 (>>) |
| LAPTM5 → BTK (>>) |
